These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25769011)

  • 1. Quantification of bindings of organometallic ruthenium complexes to GSTπ by mass spectrometry.
    Lin Y; Huang Y; Zheng W; Wu K; Luo Q; Zhao Y; Xiong S; Wang F
    J Inorg Biochem; 2015 May; 146():44-51. PubMed ID: 25769011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
    Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S
    J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.
    Liu S; Liang A; Wu K; Zeng W; Luo Q; Wang F
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs.
    Ang WH; De Luca A; Chapuis-Bernasconi C; Juillerat-Jeanneret L; Lo Bello M; Dyson PJ
    ChemMedChem; 2007 Dec; 2(12):1799-806. PubMed ID: 17918761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes.
    Wang F; Xu J; Wu K; Weidt SK; Mackay CL; Langridge-Smith PR; Sadler PJ
    Dalton Trans; 2013 Mar; 42(9):3188-95. PubMed ID: 23076358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.
    Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F
    Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organometallic ruthenium anticancer complexes inhibit human peroxiredoxin I activity by binding to and inducing oxidation of its catalytic cysteine residue.
    Lin Y; Wang J; Zheng W; Luo Q; Wu K; Du J; Zhao Y; Wang F
    Metallomics; 2019 Mar; 11(3):546-555. PubMed ID: 30693924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes.
    Liu HK; Wang F; Parkinson JA; Bella J; Sadler PJ
    Chemistry; 2006 Aug; 12(23):6151-65. PubMed ID: 16807967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
    Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
    Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
    Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
    Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the binding sites of organometallic ruthenium anticancer compounds on peptides using ultra-high resolution mass spectrometry.
    Wills RH; Habtemariam A; Lopez-Clavijo AF; Barrow MP; Sadler PJ; O'Connor PB
    J Am Soc Mass Spectrom; 2014 Apr; 25(4):662-72. PubMed ID: 24488754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry.
    Li L; Guo W; Wu K; Wu X; Zhao L; Zhao Y; Luo Q; Wang Y; Liu Y; Zhang Q; Wang F
    J Inorg Biochem; 2016 Aug; 161():99-106. PubMed ID: 27235272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action.
    Casini A; Karotki A; Gabbiani C; Rugi F; Vašák M; Messori L; Dyson PJ
    Metallomics; 2009 Sep; 1(5):434-41. PubMed ID: 21305148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective binding of an organoruthenium complex to G-rich human telomeric sequence by tandem mass spectrometry.
    Cheng Y; Zeng W; Cheng Y; Zhang J; Zou T; Wu K; Wang F
    Rapid Commun Mass Spectrom; 2018 Dec; 32(24):2152-2158. PubMed ID: 30252980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric quantification of the binding ratio of metal-based anticancer complexes with protein thiols.
    Han Y; Guo W; Zheng W; Luo Q; Wu K; Zhao Y; Wang F
    Rapid Commun Mass Spectrom; 2019 May; 33(10):951-958. PubMed ID: 30812058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.
    Castellano-Castillo M; Kostrhunova H; Marini V; Kasparkova J; Sadler PJ; Malinge JM; Brabec V
    J Biol Inorg Chem; 2008 Aug; 13(6):993-9. PubMed ID: 18491151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of clusters from reactions of ruthenium arene anticancer complex with glutathione using nanoscale liquid chromatography Fourier transform ion cyclotron mass spectrometry combined with (18)O-labeling.
    Wang F; Weidt S; Xu J; Mackay CL; Langridge-Smith PR; Sadler PJ
    J Am Soc Mass Spectrom; 2008 Apr; 19(4):544-9. PubMed ID: 18222094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.